Amylyx Pharmaceuticals, Inc. — Institutional Ownership

Which tracked institutions hold AMLX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

20
Funds holding
$375287574
Total value held
Buying
13 added/new · 7 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $122720817 8828836 -225595 -2.49%
2 Janus Henderson Group Plc $69256554 4986073 NEW BUY
3 Goldman Sachs Group Inc $36501275 2625991 +12770 +0.49%
4 State Street Corp $32847938 2363161 +293277 +14.17%
5 Franklin Resources Inc $31435812 2261569 +1061473 +88.45%
6 Morgan Stanley $30240114 2175547 -184277 -7.81%
7 Bank Of America Corp /De/ $18496577 1330689 -5321 -0.40%
8 Barclays Plc $13508771 971854 NEW BUY
9 Northern Trust Corp $10840721 779908 -157856 -16.83%
10 Bank Of New York Mellon Corp $3490342 251104 +33757 +15.53%
11 Invesco Ltd. $2125041 175914 -634726 -78.30%
12 Wells Fargo & Company/Mn $1767411 146309 +52618 +56.16%
13 Sei Investments Co $1185378 85279 NEW BUY
14 Citigroup Inc $459427 38032 -51 -0.13%
15 Prudential Financial Inc $196268 14120 NEW BUY
16 Royal Bank Of Canada $172000 12383 NEW BUY
17 Us Bancorp \De\ $28676 2063 +63 +3.15%
18 Fifth Third Bancorp $10495 755 NEW BUY
19 Pnc Financial Services Group, Inc. $3934 283 -155 -35.39%
20 Amalgamated Financial Corp. $23 1763 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.